Navigation Links
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Date:4/13/2009

NOVATO, Calif., April 13 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP) today announced the appointment of Patrice P. Rioux, M.D., Ph.D., as Chief Medical Officer ("CMO"). Dr. Rioux will be responsible for the clinical and regulatory advancement of Raptor's clinical-stage drug development programs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

Raptor's clinical programs include Delayed-Release Cysteamine ("DR Cysteamine") for the potential treatment of nephropathic cystinosis ("cystinosis"), non-alcoholic steatohepatitis ("NASH") and Huntington's Disease ("Huntington's"), as well as Convivia(TM), for the potential treatment of aldehyde dehydrogenase ("ALDH2") deficiency.

Dr. Rioux has extensive experience as a clinician, researcher, medical director and regulatory specialist. Most recently, Dr. Rioux was CMO of FerroKin Biosciences, an early-stage developer of iron chelator for treatment of anemias. Prior to that, he was CMO and Vice President Clinical/Regulatory for Edison Pharmaceuticals, which focused on developing drugs to treat inherited and acquired energy impairment diseases. Dr. Rioux' three-decade career includes industry experience at companies such as Repligen Corp., Arrow International, Variagenics, Inc., Biogen and GRP (Groupement de Recherche en Pharmacologie). He previously was a researcher in Clinical Research and Epidemiology at INSERM (Institut National de la Sante et de la Recherche Medicale), a French organization that supports national research in the medical field, from 1975 to 1995. Educated in France, Dr. Rioux has an M.D., a Ph.D. in Mathematical Statisics, and a Masters in Pharmacology.

Christopher M. Starr, Ph.D.,
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
2. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
3. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
4. Raptor Pharmaceuticals Provides Update on Targeting Platforms
5. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
6. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
7. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
8. Raptor Pharmaceuticals Provides Update of Product Programs
9. Strativa Pharmaceuticals Provides Product Pipeline Update
10. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
11. Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...November 6 , - Trial Will...for the,Treatment of Multi-Resistant Staphylococcu...peciality pharmaceutical company focused on the di...ned to overcome the significant global,problem of ...t advanced oral,antibacterial NXL103 (flopristin/l...
(Date:11/5/2009)...OND, Calif., Nov. 5 Tran...ecialty pharmaceutical company focused on the deve...cts that address important therapeutic needs in th...ost a webcast and teleconference with management t...Thursday, November 12, 2009, at 5:00 p.m. Eastern ...
(Date:11/5/2009)...Calif., Nov. 5 Renee Cobos, MD, a ...sor of dermatology at the University of California...periencing tremendous results with Thermage CPT...n tightening and contouring, features a new vibrat...nd improves patient comfort. ,, "Thermage has ...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2eMedical Systems Inc Selects MPMsoft as its Medical Billing Software Solution 55078 1eMedical Systems Inc Selects MPMsoft as its Medical Billing Software Solution 55078 2eMedical Systems Inc Selects MPMsoft as its Medical Billing Software Solution 55078 3The American Legion Can Play Key Role in Vets Suicide Prevention Says VA 55074 1The American Legion Can Play Key Role in Vets Suicide Prevention Says VA 55074 2Dopamine Lets Bad Experiences Linger 55071 1Dopamine Lets Bad Experiences Linger 55071 2Dopamine Lets Bad Experiences Linger 55071 3
...ular Therapies, Inc. (ITI),today announced it has ... 2,clinical study using its drug candidate ITI-722... receptor antagonist and represents an important n...s novel separation of 5-HT2A,and dopamine receptor...be,used not only to treat SMI but it may be highly...
...ing Pursuit, WASHINGTON, Dec. 19 The following r...oundation for Biomedical,Research:, Biomedical re...ot,worthy of pursuit" in 1980 earned Mario Capecch...tback, the Harvard-educated genetics professor,per...i filed another NIH,grant proposal, this time arme...
Other Medicine Technology:Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 2Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 3Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia 4Nobel Prize-Winning Discovery 2Nobel Prize-Winning Discovery 3
(Date:11/8/2009)... New book called "Preven...uot; by Dr. Roberto Giraldo shows that AIDS is a r...o a variety of so-called immune system stressor ag...itional and most of all, emotional. , ... -- From Nov. 6 – 8, 2009, cell biologists, ...
(Date:11/8/2009)..., WASHINGTON, Nov. 7 To...k, Pitts, Kaptur, Dahlkemper, Smith, Ellsworth and... for America Act" (H.R. 3962). The amendment maint...ing for abortion and for benefits packages that in...h those who receive affordability credits and thos...
(Date:11/8/2009)..., Calls for Swift Passage of H.R. 3961 to Secure ...PRNewswire-USNewswire/ -- Statement Attributable t...cal Association. ,, (Logo: http://www.newscom...AMA hails the passage of the House health reform b... patients and physicians and calls for swift passa...
(Date:11/8/2009)..., HOLLYWOOD, Calif., Nov. 8 /PRNewswire-USNewswire...ration of Babies luncheon to recognize prominent i...children and who are role models for March of Dime...part of the March of Dimes November Prematurity Aw...ests were urged to join the fight for preemies! ,...
(Date:11/7/2009)..., Jacquelyn T. Coleman (CT), David A. Cook (GA), ... L. Tarver (LA) Honored ,, CHICAGO, Nov. 7 /PR...iation (AMA) today presented five medical society ... their contributions to the goals and ideals of th... the AMA,s semi-annual policy making meeting in Ho...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Medical Society Executives 2
...ow footwear that has caught the fancy of the swish...y shoes //for comfy open sandals, juttis, kolhapur...India' tag! The stores are brimming with Ind...a pair of Kolhapuris at Macy's costs $75,' she say...
...ound that cutting off the reward pathway of cocain...n the brain of the mice makes them shun cocaine//....ssociate professor of pharmacology and psychiatry ...ch controls cocaine’s effects in the body. '...
...ritain-based celebrity chef Mridula Baljekar, has ...st Asian Cuisine Cookbook' category//. Baljek... Windsor, near here, received the award at a star-...y this award,' said Baljekar, whose book came from...
...n two-third (about 62 per cent) of sexual assaults...cent of victims//. Adam Negrusz, an associate ...f Illinois at Chicago College of Pharmacy said: ‘S...ay decrease their ability to identify a dangerous ...
...ched a campaign against Punjab University's (PU) m...re, saying //'enlightened moderation' is sought to... 'foreign masters'. Posters and handbills, an...alaba Mahaz (MTM), the Islamists alliance, of whic...
...about how a bacterium uses different receptors to ...ensitive to minute changes in environments of the ...op in a pool of 1,000 drops. New Cornell res...e lattice on a bacterium's surface to amplify infi...
Other Medicine News:Health News:Footwear The Hot Pick Of Summer Fashion In The West 2Health News:Students in Pakistan Protest Against Dance, Music in Curriculum 2Health News:Study Highlights How Bacteria Respond To Changes In Environment 2
Pediatric Custom Nebulizers
...R-2 assessment test approved by the U.S Food and D...is, adriamycin-based chemotherapy selection and He...rapy selection. PathVysion is the only FISH-based ...package insert as an appropriate test to aid in th...
...3 can choose either the PARI LC PLUS® or PARI ... both:, ,Maximize aerosol output when the patient...ent exhales using two one-way valves. Baffles allo.... The result is a high percentage of particles in ...
...eloping diverse medical products for more than 58 ...n outstanding reputation for innovation, quality a...nally recognized brands include the Labtron® l... sundry products, Bristoline® microscopes, Hea...
Medicine Products: